Anagenics Ltd (ASX: AN1) Share Price and News

Price

$0.006

Movement

0.00 (0.0)

as at 20 Jun - Closed (20 mins delayed)

52 Week Range

$0.005 - $0.01

 
1 Year Return

-14.29%

Anagenics Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $2.98 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 496.32 million
Earnings per share -0.017
Dividend per share N/A
Year To Date Return -25.00%
Earnings Yield N/A
Franking -
Share Price

$0.006

Day Change

0.00 (0.0)

52 Week Range

$0.005 - $0.01

Yesterday's Close

$0.006

Today's Open

$0.006

Days Range

$0.006 - $0.006

Volume

226,000

Avg. Volume (1 month)

184,754

Turnover

$1,356

as at 20 Jun - Closed

  • Anagenics Ltd (ASX: AN1)
    Latest News

    No posts found.

    AN1 ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

    About Anagenics Ltd

    Anagenics Ltd. operates as a biotechnology company, which engages in the development and marketing of therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart, and hair loss. The company was founded on October 8, 2004 and is headquartered in Sydney, Australia.

    AN1 Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    19 Jun 2025 $0.01 $0.00 0.00% 13,605 $0.01 $0.01 $0.01
    16 Jun 2025 $0.01 $0.00 0.00% 39,053 $0.01 $0.01 $0.01
    11 Jun 2025 $0.01 $0.00 0.00% 225,025 $0.01 $0.01 $0.01
    10 Jun 2025 $0.01 $0.00 0.00% 100,000 $0.01 $0.01 $0.01
    06 Jun 2025 $0.01 $0.00 0.00% 93,877 $0.01 $0.01 $0.01
    04 Jun 2025 $0.01 $0.00 0.00% 232,644 $0.01 $0.01 $0.01
    03 Jun 2025 $0.01 $0.00 0.00% 100,000 $0.01 $0.01 $0.01
    02 Jun 2025 $0.01 $0.00 0.00% 1,572,570 $0.01 $0.01 $0.01
    27 May 2025 $0.01 $0.00 0.00% 1,335,203 $0.01 $0.01 $0.01
    26 May 2025 $0.01 $0.00 0.00% 35,499 $0.01 $0.01 $0.01
    23 May 2025 $0.01 $0.00 0.00% 71,429 $0.01 $0.01 $0.01
    22 May 2025 $0.01 $0.00 0.00% 100,000 $0.01 $0.01 $0.01
    21 May 2025 $0.01 $0.00 0.00% 100,000 $0.01 $0.01 $0.01

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    16 May 2025 Alexander (Sandy) Beard Buy 55,564 $336
    On-market trade.
    14 May 2025 Alexander (Sandy) Beard Buy 5 $0
    On-market trade.
    12 May 2025 Alexander (Sandy) Beard Buy 226,876 $1,373
    On-market trade.
    08 May 2025 Alexander (Sandy) Beard Buy 267,555 $1,619
    On-market trade.
    07 May 2025 Alexander (Sandy) Beard Buy 1,950,000 $14,337
    On-market trade.
    06 May 2025 Alexander (Sandy) Beard Buy 745,933 $6,007
    On-market trade.
    05 May 2025 Alexander (Sandy) Beard Buy 1,734,067 $12,924
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Alexander (Sandy) Damien Harry Beard Non-Executive ChairmanNon-Executive Director Feb 2022
    Mr Beard is a Company Director, Investor and Investment professional focussed on driving value from small cap ASX listed companies and private equity and early-stage investments.
    Mr Phillip Christopher Non-Executive Director Nov 2021
    Mr Christopher is Investment Director of Hancock and Gore Limited, responsible for advising and guiding private investments including BLC Cosmetics prior to its acquisition by Anagenics Limited. Phillip also spent 6 years at Alceon Group where he was a director in the private equity team which made investments in e-commerce and proprietary brand-based businesses. Prior to that he was a member of the investment banking division of Goldman Sachs.
    Mr Scott Mitchell Greasley Executive Director Jul 2022
    Mr Greasley has over 15 years of experience across retail, ecommerce and wholesale within the branded consumer segment. He has led teams transforming underperforming markets across APAC, Asia and the Middle East into highly profitable regions. Scott's offering is identifying and building consumer businesses that deliver EBITDA growth, with minimal investment. Scott has experience working in both private equity and ASX-listed environments.
    Mr Hemant Amin Company Secretary Jun 2024
    -
    Hemant Amin Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Hancock & Gore 127,315,148 27.60%
    H&G High Conviction Limited 57,504,542 12.47%
    Hancock and Gore Limited 24,687,500 5.35%
    Dennis Eck 19,196,581 4.16%
    Mango Tree Management Pty Ltd 13,157,895 2.85%
    Mr Nicholas Dermott Mcdonald 13,050,225 2.83%
    P & M Maguire Super Pty Ltd <P & M Maguire S/F A/C> 8,800,000 1.91%
    Vivre Investments Pty Ltd 7,800,000 1.69%
    Bungeeltap Pty Ltd 6,000,000 1.30%
    Fordholm Consultants Pty Ltd <Diana Boehme Super Fund A/C> 6,000,000 1.30%
    Maria Halasz 5,047,305 1.09%
    Mr Phillip Thuaux 4,794,989 1.04%
    Cannington Corporation Pty Limited <Cannington Super Fund A/C> 4,550,000 0.99%
    Mr Antony Stephen Iles 4,502,685 0.98%
    Dr Ida Constable 3,740,637 0.81%
    Ubs Nominees Pty Ltd 3,663,378 0.79%
    Mr Alexander Beard 3,125,000 0.68%
    L X X X I X Pty Ltd 3,016,675 0.65%
    Mr Hugh Alexander Robertson & Mrs Lisa Ann Scott <Hala Super Fund A/C> 3,000,000 0.65%
    Ms Catherine Robertson & Ms Hannah Robertson <HCH Robertson S/F A/C> 3,000,000 0.65%

    Profile

    since

    Note